查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566838

血糖监测设备市场：按设备、患者类型和最终用户划分：2024-2033 年全球机会分析和产业预测

Glucose Monitoring Devices Market By Device, By Patient Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

血糖监测设备市场

2023年，血糖监测设备市场价值为147亿美元，预计2024年至2033年复合年增长率为10.2%，到2033年达到389亿美元。

血糖监测涉及测量和追踪个体血液或组织液中的血糖浓度。它是有效管理糖尿病患者的重要常规，因为它提供全天血糖值波动的资料，以响应饮食摄取、压力、体力活动和药物等多种因素。血糖监测设备的即时或定期血糖读数使您能够就饮食选择、药物剂量和生活方式调整做出明智的决定。血糖监测设备是预防与糖尿病相关的短期和长期併发症的重要设备。

肥胖和糖尿病等与文明病盛行率不断上升，是血糖监测设备市场的主要驱动因素。此外，个人对自我监控行动装置的需求正在迅速增加，这有助于开拓市场。目前，非侵入性血糖监测设备是市场的趋势。光学感测器和微针贴片是市场上最常见的设备之一。此外，资料分析的整合正在受到个人和医疗保健提供者的关注，因为它有助于识别模式和趋势，从而有助于主动的疾病管理和预防。

然而，由于血糖测试结果的高可靠性，许多人坚持传统的血糖测试方法，这对新型和创新的血糖监测设备的广泛采用提出了挑战。此外，新监控设备的核准过程非常严格且耗时，往往会延迟新产品推向市场的时间。相较之下，科学家不断努力推出创新产品，为市场扩张提供了有利可图的机会。例如，沙乌地阿拉伯阿卜杜拉国王科技大学的研究人员开发了一种原型感测器，可以使用唾液测量血糖浓度。预计该设备未来将成为个人测量血糖值的简单、快速、无痛的方式。

按部门审查

血糖监测设备市场分为设备、患者类型、最终用户和地区。依装置分为血糖仪、连续血糖监测系统、快速血糖监测系统、智慧型手机应用程式和穿戴式装置。依患者类型分为第1型糖尿病和第2型糖尿病。依最终使用者划分，可分为医院/诊所、居家照护环境等。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按设备划分，连续血糖监测设备领域在 2023 年的市场收益最高。

按患者类型划分，1 型糖尿病细分市场将成为 2023 年的最大股东。

按最终用户划分，居家照护细分市场 2023 年收益最高。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章血糖监测设备市场：依设备分类

  • 市场概况
  • 血糖仪
  • 连续血糖监测装置
  • 快速血糖监测装置
  • 智慧型手机应用程式和穿戴式装置

第五章血糖监测设备市场：依患者类型

  • 市场概况
  • 1型糖尿病
  • 2型糖尿病

第六章血糖监测设备市场：依最终用户分类

  • 市场概况
  • 医院和诊所
  • 居家医疗
  • 其他的

第七章血糖监测设备市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国血糖监测设备市场
    • 加拿大血糖监测设备市场
    • 墨西哥血糖监测设备市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国血糖监测设备市场
    • 德国血糖监测设备市场
    • 义大利血糖监测设备市场
    • 西班牙血糖监测设备市场
    • 英国血糖监测设备市场
    • 其他欧洲血糖监测设备市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国血糖监测设备市场
    • 日本血糖监测设备市场
    • 印度血糖监测设备市场
    • 韩国血糖监测设备市场
    • 澳洲血糖监测设备市场
    • 其他亚太地区血糖监测设备市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西血糖监测设备市场
    • 南非血糖监测设备市场
    • 沙乌地阿拉伯血糖监测设备市场
    • 其他拉丁美洲/中东/非洲血糖监测设备市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Menarini Diagnostics SRL
  • Senseonics, A.
  • Novo Nordisk A/S
  • GlySens Incorporated
  • Johnson And Johnson
  • DexCom, Inc.
  • Medtronic Plc
  • F. Hoffman-La Roche Ltd
  • Abbott Laboratories
  • B. Braun SE
简介目录
Product Code: A62953

Glucose Monitoring Devices Market

The glucose monitoring devices market was valued at $14.7 billion in 2023 and is projected to reach $38.9 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.

Glucose monitoring involves the measuring and tracking the glucose levels in the blood or interstitial fluid of individuals. It is an essential routine for individuals with diabetes for effective management, as it provides data about fluctuations in blood sugar levels throughout the day in response to several factors such as food intake, stress, physical activity, and medication. The real-time or periodic glucose readings provided glucose monitoring devices allow individuals to make informed decisions regarding dietary choices, medication dosage, and lifestyle adjustments. Glucose monitoring devices are critical equipment for the prevention of short-term and long-term complications associated with diabetes.

Increase in prevalence of lifestyle diseases, including obesity and diabetes, is a major driver of the glucose monitoring devices market. In addition, the demand for self-monitoring portable devices is surging among individuals, hence augmenting the development of the market. Non-invasive glucose monitoring devices are trending in the market currently. Optical sensors and microneedle patches are among the most common equipment available in the market. Furthermore, the integration of data analytics is acquiring traction from individuals and healthcare providers as it aids to identify patterns and trends, thereby assisting in proactive management and prevention of diseases.

However, a large base of individuals adheres to the traditional method of glucose testing owing to high confidence in its results, which presents challenges for the widespread adoption of new & innovative glucose monitoring devices. Moreover, the approval process of new monitoring devices is highly stringent and lengthy, which often delays the introduction of novel products into the market. Contrarily, the constant efforts of scientists to launch innovative products present lucrative opportunities for the expansion of the market. For instance, researchers of the King Abdullah University of Science & Technology, Saudi Arabia developed a prototype for a sensor that measures glucose levels using saliva. This device is projected to be a simple, quick, and painless way for individuals to measure blood glucose in the future.

Segment Review

The glucose monitoring devices market is segmented into device, patient type, end user, and region. On the basis of device, the market is divided into blood glucose meters, continuous glucose monitoring systems, flash glucose monitoring systems, smartphone apps, and wearables. By patient type, it is bifurcated into type 1 diabetes and type 2 diabetes. According to end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of device, the continuous glucose monitoring devices segment generated the highest revenue in the market in 2023.

By patient type, the type 1 diabetes segment was the highest shareholder in 2023.

According to end user, the home care settings segment was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global glucose monitoring devices market include Menarini Diagnostics S.R.L., Senseonics, A., Novo Nordisk A/S, GlySens Incorporated, Johnson & Johnson, DexCom, Inc., Medtronic plc, F. Hoffman-La Roche Ltd, Abbott laboratories, and B. Braun SE. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Device

  • Blood Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Flash Glucose Monitoring Systems
  • Smartphone Apps and Wearables

By Patient Type

  • Type 1 Diabetes
  • Type 2 Diabetes

By End User

  • Hospitals and Clinics
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Menarini Diagnostics S.R.L.
    • Senseonics, A.
    • Novo Nordisk A/S
    • GlySens Incorporated
    • Johnson & Johnson
    • DexCom, Inc.
    • Medtronic plc
    • F. Hoffman-La Roche Ltd
    • Abbott laboratories
    • B. Braun SE

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: GLUCOSE MONITORING DEVICES MARKET, BY DEVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Device
  • 4.2. Blood Glucose Meters
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Continuous Glucose Monitoring Systems
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Flash Glucose Monitoring Systems
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Smartphone Apps And Wearables
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: GLUCOSE MONITORING DEVICES MARKET, BY PATIENT TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Patient Type
  • 5.2. Type 1 Diabetes
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Type 2 Diabetes
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: GLUCOSE MONITORING DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Home Care Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: GLUCOSE MONITORING DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Device
    • 7.2.3. Market Size and Forecast, By Patient Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Glucose Monitoring Devices Market
      • 7.2.6.1. Market Size and Forecast, By Device
      • 7.2.6.2. Market Size and Forecast, By Patient Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Glucose Monitoring Devices Market
      • 7.2.7.1. Market Size and Forecast, By Device
      • 7.2.7.2. Market Size and Forecast, By Patient Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Glucose Monitoring Devices Market
      • 7.2.8.1. Market Size and Forecast, By Device
      • 7.2.8.2. Market Size and Forecast, By Patient Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Device
    • 7.3.3. Market Size and Forecast, By Patient Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Glucose Monitoring Devices Market
      • 7.3.6.1. Market Size and Forecast, By Device
      • 7.3.6.2. Market Size and Forecast, By Patient Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Glucose Monitoring Devices Market
      • 7.3.7.1. Market Size and Forecast, By Device
      • 7.3.7.2. Market Size and Forecast, By Patient Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Glucose Monitoring Devices Market
      • 7.3.8.1. Market Size and Forecast, By Device
      • 7.3.8.2. Market Size and Forecast, By Patient Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Glucose Monitoring Devices Market
      • 7.3.9.1. Market Size and Forecast, By Device
      • 7.3.9.2. Market Size and Forecast, By Patient Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Glucose Monitoring Devices Market
      • 7.3.10.1. Market Size and Forecast, By Device
      • 7.3.10.2. Market Size and Forecast, By Patient Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Glucose Monitoring Devices Market
      • 7.3.11.1. Market Size and Forecast, By Device
      • 7.3.11.2. Market Size and Forecast, By Patient Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Device
    • 7.4.3. Market Size and Forecast, By Patient Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Glucose Monitoring Devices Market
      • 7.4.6.1. Market Size and Forecast, By Device
      • 7.4.6.2. Market Size and Forecast, By Patient Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Glucose Monitoring Devices Market
      • 7.4.7.1. Market Size and Forecast, By Device
      • 7.4.7.2. Market Size and Forecast, By Patient Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Glucose Monitoring Devices Market
      • 7.4.8.1. Market Size and Forecast, By Device
      • 7.4.8.2. Market Size and Forecast, By Patient Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Glucose Monitoring Devices Market
      • 7.4.9.1. Market Size and Forecast, By Device
      • 7.4.9.2. Market Size and Forecast, By Patient Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Glucose Monitoring Devices Market
      • 7.4.10.1. Market Size and Forecast, By Device
      • 7.4.10.2. Market Size and Forecast, By Patient Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Glucose Monitoring Devices Market
      • 7.4.11.1. Market Size and Forecast, By Device
      • 7.4.11.2. Market Size and Forecast, By Patient Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Device
    • 7.5.3. Market Size and Forecast, By Patient Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Glucose Monitoring Devices Market
      • 7.5.6.1. Market Size and Forecast, By Device
      • 7.5.6.2. Market Size and Forecast, By Patient Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Glucose Monitoring Devices Market
      • 7.5.7.1. Market Size and Forecast, By Device
      • 7.5.7.2. Market Size and Forecast, By Patient Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Glucose Monitoring Devices Market
      • 7.5.8.1. Market Size and Forecast, By Device
      • 7.5.8.2. Market Size and Forecast, By Patient Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Glucose Monitoring Devices Market
      • 7.5.9.1. Market Size and Forecast, By Device
      • 7.5.9.2. Market Size and Forecast, By Patient Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Menarini Diagnostics S.R.L.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Senseonics, A.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Novo Nordisk A/S
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. GlySens Incorporated
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Johnson And Johnson
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. DexCom, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Medtronic Plc
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. F. Hoffman-La Roche Ltd
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Abbott Laboratories
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. B. Braun SE
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments